Fuller Smith & Turne a Aktie 3192856 / GB00B1YPC344
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
06.11.2025 18:51:55
|
Fuller, Smith & Turner PLC: Transaction in own shares
|
Fuller, Smith & Turner PLC (FSTA)
Fuller, Smith & Turner P.L.C. (“the Company” or “Fuller’s”)
Transaction in own shares
The Company announces that it has purchased the following number of its “A” Ordinary Shares of 40p each on the London Stock Exchange through Numis Securities Limited as part of its share buyback programme announced on 28 August 2025 (the “Programme”).
The Company intends to hold the repurchased shares in Treasury. Following the purchase of the said shares, Fuller’s listed issued share capital consists of 36,391,365 “A” Ordinary Shares of 40p each. Of this total 4,132,172 “A” Ordinary Shares are held in Treasury. Therefore, the total number of listed voting rights in the Company for the purpose of Disclosure and Transparency Rule 5.6.1 (calculated in accordance with Disclosure and Transparency Rule 5.6.2) is 32,259,193. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in Fuller’s, under the FCA's Disclosure and Transparency Rules. In accordance with Article 5(1)(b) of Regulation (EU) no 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made.
Enquiries: Rachel Spencer Company Secretary 020 8996 2073
6 November 2025
SCHEDULE OF PURCHASES
Shares Purchased: “A” Ordinary Shares of 40p each Date of Purchase: 6 November 2025 Investment Firm: Numis Securities Limited
Aggregate Information:
Individual Transactions:
---End--- Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. |
| ISIN: | GB00B1YPC344 |
| Category Code: | POS |
| TIDM: | FSTA |
| LEI Code: | 213800C7ACOFMRCQQW76 |
| Sequence No.: | 407464 |
| EQS News ID: | 2225510 |
| End of Announcement | EQS News Service |
|
|
Nachrichten zu Fuller Smith & Turner PLC (A)
|
06.11.25 |
Fuller, Smith & Turner PLC: Transaction in own shares (EQS Group) | |
|
03.11.25 |
Fuller, Smith & Turner PLC: Transaction in own shares (EQS Group) | |
|
03.11.25 |
Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares (EQS Group) | |
|
31.10.25 |
Fuller, Smith & Turner PLC: Transaction in own shares (EQS Group) | |
|
30.10.25 |
Fuller, Smith & Turner PLC: Transaction in own shares (EQS Group) | |
|
30.10.25 |
Fuller, Smith & Turner PLC: (EQS Group) | |
|
29.10.25 |
Fuller, Smith & Turner PLC: Transaction in own shares (EQS Group) | |
|
28.10.25 |
Fuller, Smith & Turner PLC: Transaction in own shares (EQS Group) |
Analysen zu Fuller Smith & Turner PLC (A)
Abnehmspritzen – Ist der Hype vorbei? – mit Tim Schäfer
Ist der Hype um Abnehmspritzen wie bei Novo Nordisk und Eli Lilly vorbei – oder stehen wir erst am Anfang einer langfristigen Revolution im Gesundheitswesen? 💉📉
Im heutigen Gespräch mit Tim Schäfer @TimSchaeferMedia sprechen wir über die spannendsten Pharmawerte 2025. Neben den Abnehmspritzen blicken wir auch auf klassische Pharma-Giganten wie Pfizer, Johnson & Johnson, Roche, Novartis, AstraZeneca und GSK. Tim analysiert Übertreibungen, Rücksetzer und langfristige Chancen für Buy-and-Hold-Strategien – mit Fokus auf Dividende, KGV und Krisenresistenz.
💬 Was ist vom Abnehmtrend langfristig zu halten?
💬 Welche Pharma-Aktien sind aktuell unterbewertet?
💬 Was spricht für konservative Dividendenwerte im Gesundheitssektor?
👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
SMI wenig verändert erwartet -- DAX stabil erwartet -- Asiens Börsen schwächerDer heimische Aktienmarkt soll ruhig in den letzten Handelstag der Woche starte, während der deutsche Aktienmarkt die Sitzung auf Vortagsniveau beginnen soll. An den Märkten in Fernost geht es zum Wochenende nach unten.


